Paper Review Records
全部论文审稿周期
30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
144
天
Zanubrutinib monotherapy in CD79B ‐mutated relapsed or refractory diffuse large B‐cell lymphoma: A multicenter Phase 2 study
作者
Li Wang; Keshu Zhou; Fei Li; Qingyuan Zhang; Hui Zhou; Ou Bai; Liping Su; Chunhong Hu; Zhi‐Ming Li; Kaiyang Ding; Qunyi Guo; Xiaoling Li; Xiaoxi Zhou; Wenjuan Yu; Shuhua Yi; Zhixia Wei; Wenbin Qian; Feiheng Chen; Guohui Cui; Zhiyu Liang; Qingchao Zeng; Jiaoyan Lyu; Yang Liu; Pan Zhang; Zhirong Shen; Zaixing Shi; Jing Rong; Wei‐Li Zhao展开收起
作者单位
1. Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China; 2. The Affiliated Cancer Hospital of Zhengzhou University & HeNan Cancer Hospital Zhengzhou China; 3. The First Affiliated Hospital of Nanchang University Nanchang China; 4. Harbin Medical University Cancer Hospital Harbin China; 5. Hunan Cancer Hospital Changsha China; 6. The First Hospital of Jilin University Changchun China; 7. Shanxi Provincial Cancer Hospital Taiyuan China; 8. The Second Xiangya Hospital of Central South University Changsha China; 9. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer Sun Yat‐sen University Cancer Center Guangzhou China; 10. Anhui Provincial Cancer Hospital Hefei China; 11. Taizhou Hospital of Zhejiang Province Taizhou China; 12. Liaoning Cancer Hospital & Institute Shenyang China; 13. Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan China; 14. The First Affiliated Hospital of Zhejiang University Hangzhou China; 15. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin China; 16. Tianjin Institutes of Health Science Tianjin China; 17. Hainan Cancer Hospital Haikou China; 18. Zhejiang University College of Medicine‐Second Affiliated Hospital Hangzhou China; 19. The First Affiliated Hospital of Shantou University Medical College Shantou China; 20. Union Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan China; 21. BeOne Medicines, Ltd. Shanghai China; 22. BeOne Medicines, Ltd. Beijing China展开收起
63
天
The maturation of precision medicine into pragmatic, patient‐centered care: A commentary on the 2026 EHA CLL Guidelines
作者
Stefano Molica; Talha Munir; David Allsup展开收起
作者单位
1. Department of Haematology Hull York Medical School Hull United Kingdom; 2. Department of Haematology St James's University Hospital Leeds United Kingdom; 3. Centre for Biomedicine, Hull York Medical School Hull United Kingdom展开收起
136
天
Long‐term mutational analysis, clonal metrics, and dynamics in patients with chronic idiopathic neutropenia
作者
Grigorios Tsaknakis; Irene Mavroudi; Marco Roncador; Anna Maria Perantonaki; Erasmia Boutakoglou; Stavros Papadakis; Anna Gallì; Stamatia Laidou; Charalampos Pontikoglou; Anastasia Chatzidimitriou; Luca Malcovati; Helen A. Papadaki展开收起
作者单位
1. Department of Hematology, University Hospital of Heraklion, and Hemopoiesis Research Laboratory, School of Medicine University of Crete Heraklion Greece; 2. Unit of Molecular Hematology and Precision Medicine IRCCS Fondazione Policlinico San Matteo Pavia Italy; 3. Department of Medical Oncology and Hematology University Hospital Zurich Zurich Switzerland; 4. Department of Molecular Medicine University of Pavia Pavia Italy; 5. Institute of Applied Biosciences, Centre for Research and Technology Hellas Thessaloniki Greece展开收起
12
天
Integrating paroxysmal nocturnal hemoglobinuria (PNH) into mainstream hematological curriculum training
作者
Morag Griffin; Richard Kelly; Colm Bradley; Sam Salek; Richard Soutar; Argiris Symeonidis展开收起
作者单位
1. St James Hospital, Leeds Teaching Hospital NHS Trust Leeds United Kingdom; 2. University of Glasgow Glasgow United Kingdom; 3. University of Hertfordshire Hatfield United Kingdom; 4. Beatson, West of Scotland Cancer Centre Glasgow United Kingdom; 5. University of Patras Patras Greece展开收起
75
天
DDX41 mutations establish a separate entity in acute myeloid leukemia with distinct survival outcomes
作者
Carolin Seeling; Maral Saadati; Daniela Späth; Michael Heuser; Felicitas Thol; Arnold Ganser; Elli Papaemmanuil; Lars Bullinger; Axel Benner; Hartmut Döhner; Konstanze Döhner展开收起
作者单位
1. Department of Internal Medicine III University Hospital of Ulm Ulm Germany; 2. Division of Biostatistics German Cancer Research Center (DKFZ) Heidelberg Germany; 3. Department of Internal Medicine IV University Hospital Halle (Saale), Martin Luther University Halle‐Wittenberg Halle (Saale) Germany; 4. Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School Hannover Germany; 5. Department of Computational Oncology, Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Center New York New York United States of America; 6. Department of Hematology, Oncology and Cancer Immunology Charité‐Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt‐Universität zu Berlin Berlin Germany; 7. German Cancer Consortium (DKTK) Partner Site Berlin Germany; 8. National Center for Tumor Diseases (NCT) Partner Site Berlin Germany展开收起
139
天
High‐dimensional spectral flow cytometry uncovers progressive T‐cell exhaustion and myeloid cell reprogramming in a CLL mouse model
作者
Hannah Briesch; Mariana Coelho; Alessia Floerchinger; Yuliia Borysovych; Nicolas Aubert; Daniel Medina‐Gil; Manina Breitinger; Marc Zapatka; Stella E. Autenrieth; Martina Seiffert展开收起
作者单位
1. Immune Modulation in Cancer German Cancer Research Center (DKFZ) Heidelberg Germany; 2. Division of Molecular Genetics German Cancer Research Center (DKFZ) Heidelberg Germany; 3. Faculty of Biosciences Heidelberg University Heidelberg Germany; 4. Dendritic Cells in Infection and Cancer German Cancer Research Center (DKFZ) Heidelberg Germany展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
